Shaorong Chong of New England Biolabs in the U.S. will synthetically reconstruct essential biological processes of Mycobacterium tuberculosis and use this system as a drug-testing platform for the screening of small-molecule therapeutics against multi-drug resistant M. tuberculosis.
Grant ID
OPP1057809
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False